Ocular adverse reactions associated with intraocular pressure-reducing drugs: An analysis of the FDA adverse event reporting system (FAERS) [0.03%]
与降眼压药物相关的眼部不良反应：来自美国食品药品监督管理局不良事件监测系统的分析
Chengzhi Liu,Shuaihao Zhang,Xinyu Wang et al.
Chengzhi Liu et al.
BackgroundIntraocular pressure (IOP)-lowering drugs are essential for glaucoma treatment but can cause ocular and systemic adverse events (AEs). This study utilizes the FDA Adverse Event Reporting System (FAERS) database to investigate the ...
Use of nootropics in Alzheimer's disease: An analysis of regulatory positions and drug policies in the countries of the Commonwealth of Independent States [0.03%]
独联体国家阿尔茨海默病认知兴奋剂使用的监管立场和药物政策分析
Elvira Grigorievna Alexandrova,Tatyana Rudolfovna Abakumova,Liliya Eugenevna Ziganshina
Elvira Grigorievna Alexandrova
ObjectiveTo analyse regulatory positions and drug policies of the Commonwealth of Independent States (CIS), compared to those of the EU, UK, USA i of the nootropics, used in Russia for Alzheimer's disease.MethodsWe searched E-library to rev...
Risk management plans and drug safety in Canada: A cross-sectional study [0.03%]
加拿大药品安全性的风险管理体系现状研究：横断面研究
Joel Lexchin
Joel Lexchin
BackgroundHealth Canada uses risk management plans (RMPs) to identify and monitor risks associated with drugs in the postmarket phase but does not make the contents of these RMPs public.ObjectiveTo identify information about RMPs that is av...
Detection of cyclophosphamide residues on community pharmacy counters: An exploratory survey [0.03%]
社区药房台面环磷酰胺残留物的检测：一项探索性调查
Masato Komuro,Hisanaga Nomura,Takahito Furuya et al.
Masato Komuro et al.
ObjectiveThis study aimed to evaluate cyclophosphamide contamination in community pharmacies, investigate patient-mediated transfer and indirect risks to the public, and examine the association between the use of hospital closed system tran...
The importance of nutrivigilance in Middle East countries and the necessity for incorporation into pharmacovigilance health authorities' regulations [0.03%]
中东国家营养警戒的重要性及其在药品监管机构法规中必要性的纳入
Samer Shukur Mohammed
Samer Shukur Mohammed
BackgroundNutrivigilance has become increasingly vital as global supplement consumption rises. However, in many Middle Eastern countries, these products are marketed with limited oversight and minimal integration within existing pharmacovig...
Bayram Goktas,Deniz Tugay Arslan,Yasemin Hancioglu Baskoy et al.
Bayram Goktas et al.
BackgroundOccupational safety is the set of measures and practices taken to ensure that employees are protected from the dangers they may be exposed to in the workplace. Its measures prevent occupational accidents and occupational diseases,...
Flurbiprofen-induced upper respiratory and ocular adverse effects in a patient having non-cardiac chest pain [0.03%]
氟比洛芬致上呼吸道和眼部不良反应病例报告（非心脏性胸痛患者）
Erkan Gencer
Erkan Gencer
BackgroundFlurbiprofen (FLU) is a phenylalkanoic acid derivative which is one of the most commonly used nonsteroidal anti-inflammatory drug (NSAID).Case presentationA 27-year-old woman with no known previous diseases presented with chest pa...
ATC/DDD analysis of expired and unused medicines collected through separate collection [0.03%]
药品失效和未使用药物的ATC/DDD分析（通过单独收集）
Odina Makhmudova,Rasima Tukhtaeva,Pavel Vasilyev et al.
Odina Makhmudova et al.
IntroductionIrrational use and improper disposal of medicines lead to environmental pollution. There is compelling evidence of the negative impact of medications on biological systems. In Russia, there is no legislation regarding the dispos...
Quality of safety reports on oral anticoagulants in the Russian state pharmacovigilance database. A cross-sectional study for 2017-2022 [0.03%]
2017至2022年俄罗斯国家药物警戒数据库中口服抗凝药安全报告质量的横断面研究
Aleksandr V Matveev,Sergey V Glagolev,Elena A Kruglova et al.
Aleksandr V Matveev et al.
Background: Quality of individual cases of safety reports (ICSR) is a challenge for modern drug safety studies. Purpose and Research Design: In this cross-sectional study of the safety database, we studied reports completeness for direct or...
Pharmacoepidemiological analysis of antiplatelet drug consumption in outpatient practice [0.03%]
抗血小板药物门诊使用情况的药物流行病学分析
Dariya V Ivanova,Ayrat Usmanovich Ziganshin,Rustem N Khairullin et al.
Dariya V Ivanova et al.
BackgroundAcute coronary syndrome remains a leading cause of mortality, making antiplatelet therapy crucial for the treatment and secondary prevention of this condition. PurposeWe aimed to analyze consumption of antiplatelet drugs in the ou...